All Stories

  1. Clinopodium tomentosum (Kunth) Govaerts Leaf Extract Influences in vitro Cell Proliferation and Angiogenesis on Primary Cultures of Porcine Aortic Endothelial Cells
  2. QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS
  3. Fruit Quality Characterization of New Sweet Cherry Cultivars as a Good Source of Bioactive Phenolic Compounds with Antioxidant and Neuroprotective Potential
  4. Analytica—A Journal of Analytical Chemistry and Chemical Analysis
  5. Dried Urine Microsampling Coupled to Liquid Chromatography—Tandem Mass Spectrometry (LC–MS/MS) for the Analysis of Unconjugated Anabolic Androgenic Steroids
  6. Microsampling and LC–MS/MS for antidoping testing of glucocorticoids in urine
  7. Metabolic Syndrome in Schizophrenia: Focus on the Role of Antipsychotic Medications and Indications for Therapeutic Drug Monitoring (TDM) Methods
  8. New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others
  9. Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption
  10. Assessment of capillary volumetric blood microsampling for the analysis of central nervous system drugs and metabolites
  11. Changes in carotenoids, phenolic acids and antioxidant capacity in bread wheat doughs fermented with different lactic acid bacteria strains
  12. Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation
  13. An Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical Generation via Fenton Chemistry
  14. In Vitro Anti-Inflammatory Effect of Salvia sagittata Ethanolic Extract on Primary Cultures of Porcine Aortic Endothelial Cells
  15. Perspectives and strategies for anti-doping analysis
  16. Tutorial: Volumetric absorptive microsampling (VAMS)
  17. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches
  18. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
  19. Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection
  20. Integrated Evaluation of the Potential Health Benefits of Einkorn-Based Breads
  21. Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
  22. Analytical profiling of selected antioxidants and total antioxidant capacity of goji ( Lycium spp.) berries
  23. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease
  24. TDM of novel antipsychotics
  25. Discontinued anxiolytic drugs (2009 – 2014)
  26. Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
  27. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients
  28. A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma
  29. Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety
  30. Recent trends in the analysis of amino acids in fruits and derived foodstuffs
  31. Monitoring of chronic Cannabis abuse: An LC–MS/MS method for hair analysis
  32. Quantitative Evaluation of Auraptene and Umbelliferone, Chemopreventive Coumarins in Citrus Fruits, by HPLC-UV-FL-MS
  33. Dried blood spots: Liquid chromatography–mass spectrometry analysis of Δ9-tetrahydrocannabinol and its main metabolites
  34. Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
  35. Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method
  36. Fast analysis of amino acids in wine by capillary electrophoresis with laser-induced fluorescence detection
  37. Chiral analysis of amphetamines, methadone and metabolites in biological samples by electrodriven methods
  38. Determination of aloe emodin in Aloe vera extracts and commercial formulations by HPLC with tandem UV absorption and fluorescence detection
  39. Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
  40. Determination of topiramate in human plasma by capillary electrophoresis with indirect UV detection
  41. Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: an Analytical Point of View
  42. Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: A novel test for cocaine and alcohol intake
  43. Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma
  44. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements
  45. Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma
  46. Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE
  47. Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection
  48. Enantioseparation of the antidepressant reboxetine
  49. Benzodiazepine Metabolism: An Analytical Perspective
  50. Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection
  51. Separation and HPLC analysis of 15 benzodiazepines in human plasma
  52. New environmental sensitive system for colon-specific delivery of peptidic drugs
  53. Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresis
  54. Electrodriven methods for the enantioseparation of second-generation antidepressant drugs: An update
  55. Determination of vigabatrin in human plasma by means of CE with LIF detection
  56. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
  57. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
  58. Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection
  59. Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
  60. Analysis of aromatic and terpenic constituents of pepper extracts by capillary electrochromatography
  61. Possible levomepromazine–clozapine interaction: Two case reports
  62. Sensitive and selective determination of glutathione in probiotic bacteria by capillary electrophoresis–laser induced fluorescence
  63. Determination of amphetamines in human urine by liquid chromatography with fluorimetric detection using a solid-phase extraction procedure
  64. Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure
  65. Capillary electrophoretic analysis of the antibiotic vancomycin in innovative microparticles and in commercial formulations
  66. HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma
  67. Fluoxetine Metabolism and Pharmacological Interactions: The Role of Cytochrome P450
  68. Enantioseparation and quality control of biperiden in pharmaceutical formulations by capillary electrophoresis
  69. Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection
  70. Advances in the enantioseparation of second-generation antidepressant drugs by electrodriven methods
  71. Separation and analysis of glycyrrhizin, 18β-glycyrrhetic acid and 18α-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis
  72. Separation and analysis of the major constituents of cloves by micellar electrokinetic chromatography
  73. Enantioselective determination of the novel antidepressant mirtazapine and its active demethylated metabolite in human plasma by means of capillary electrophoresis
  74. Rapid analysis of olanzapine and desmethylolanzapine in human plasma using high-performance liquid chromatography with coulometric detection
  75. Simultaneous liquid chromatographic analysis of catecholamines and 4-hydroxy-3-methoxyphenylethylene glycol in human plasma
  76. Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions
  77. Micelles Based on Polyvinyl Alcohol Substituted with Oleic Acid for Targeting of Lipophilic Drugs
  78. High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures
  79. Analysis of plasma catecholamines by liquid chromatography with amperometric detection using a novel SPE ion-exchange procedure
  80. Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis
  81. Quality control of commercial tablets containing the novel antipsychotic quetiapine
  82. Determination of melatonin in commercial preparations by micellar electrokinetic chromatography and spectrofluorimetry
  83. Liquid chromatographic analysis of the cis(Z)- and trans(E)-isomers of clopenthixol in human plasma using a novel solid phase extraction procedure
  84. Determination of recent antidepressant citalopram in human plasma by liquid chromatography—Fluorescence detection
  85. Determination of progesterone in commercial formulations and in non conventional micellar systems
  86. Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction
  87. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma
  88. Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction
  89. Rapid methods for determination of fluoxetine in pharmaceutical formulations
  90. Determination of reboxetine, a recent antidepressant drug, in human plasma by means of two high-performance liquid chromatography methods
  91. Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients
  92. Rapid capillary electrophoretic method for the determination of clozapine and desmethylclozapine in human plasma
  93. A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure
  94. Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry
  95. A rapid LC method for the identification and determination of CNS drugs in pharmaceutical formulations
  96. DEVELOPMENT OF AN HPLC METHOD FOR THE TOXICOLOGICAL SCREENING OF CENTRAL NERVOUS SYSTEM DRUGS
  97. Spectrophotometric determination of silicate traces in hemodialysis solutions
  98. Analytical methods for the quality control of Prozac® capsules
  99. Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detection
  100. Determination of clozapine in human plasma by solid-phase extraction and liquid chromatography with amperometric detection
  101. Comparison of analytical methods for quality control of pharmaceutical formulations containing glutathione